Medpace Holdings MEDP Insider Ownership

Updated Oct 10, 2026

Across the past 12 months, open-market trades by Medpace Holdings insiders were all sales, totaling $467.02 million (778.61K shares).

• A count shows 9 insiders selling MEDP stock on the open market over the past 12 months and none buying.
• August J. Troendle (President & CEO) was MEDP's largest open-market seller in the past 12 months, with $358.45 million of sales (586.38K shares); the latest was on September 30, 2026.
• Outside the open market, Medpace Holdings insiders acquired 192.87K shares through option exercises and conversions and gave away 170 shares as gifts over the past 12 months.
• Business Quant data shows Medpace Holdings insiders holding 5.23Mn shares in total in their latest Form 4 filings, or 18.58% of the 28.17Mn shares outstanding; that total is down 5.64% from 5.55Mn shares at the end of Q2 2026 and down 10.07% from 5.82Mn shares at the end of Q3 2025.
• Direct holdings account for 499.33K shares (9.54%) of MEDP's insider total, and indirect holdings through trusts, partnerships and family members for 4.74Mn shares (90.46%).
• Holdings in Medpace Holdings stock are reported by 9 insiders, the officers, directors and 10% owners who have filed a Form 4 in the past two years.
• Medpace Holdings' three biggest insider holders are August J. Troendle (President & CEO, 5.07Mn shares), Susan E. Burwig (Executive VP, Operations, 67.98K shares) and Brian T. Carley (Director, 27.86K shares), based on their latest Form 4 filings.
• August J. Troendle alone accounts for 96.88% of the shares held by Medpace Holdings insiders.
• Over the past 12 months, 11 insiders reported transactions in Medpace Holdings stock in 72 Form 4 filings.
• This summary of Medpace Holdings insider activity covers Form 4 filings through October 9, 2026.